Daraasad iskaashi oo ay hogaaminayaan Machadka Discovery Monash Biomedicine (BDI) oo ay la socdaan Peter Doherty Institute of Infection and Immunity (Doherty Institute), oo ay iska kaashadeen Jaamacada Melbourne iyo Royal Melbourne Hospital, ayaa muujisay in dawada ladagaalanka dulin jirka ee horey looga helay aduunka ay ku disho viruska 48 saacadood gudahood.
In kasta oo dhowr tijaabo caafimaad ay hadda socdaan si loo tijaabiyo daaweynta suurtagalka ah, jawaabta adduunka oo dhan ee COVID-19 dillaaca ayaa inta badan ku koobnayd kormeerka / xakameynta. Ivermectin, oo ah FDA-la ansixiyay anti-parasitic horey loogu muujiyey inuu leeyahay firfircooni ballaaran oo ah anti-viral anti-viral in vitro, waa kahortaga fayraska keena.
Isticmaalka Ivermectin si loola dagaallamo COVID-19 waxay kuxirantahay baaritaanka hore ee daaweynta iyo tijaabooyinka bukaan socodka, iyadoo maalgelin deg deg ah looga baahan yahay in lagu hormariyo shaqada.
Australia gudaheeda, daraasad iskaashi oo ay hogaamiso Jaamacadda Monash ayaa lagu daabacay Cilmi-baarista fayraska, joornaal caafimaad oo asaagtiisa dib loo eegay https://doi.org/10.1016/j.antiviral.2020.104787
Machadka baaritaanka Monash Biomedicine's Dr Kylie Wagstaff, oo hogaaminayay daraasadan, ayaa sheegay in saynisyahannadu muujiyeen in daroogada, Ivermectin, ay joojisay fayraska SARS-CoV-2 ee ku sii kordhaya dhaqanka unugyada muddo 48 saacadood gudahood ah.
"Waxaan ogaanay in xitaa hal qaadasho ay muhiimad weyn ka qaadi karto dhammaan fayraska RNA 48 saacadood iyo xitaa 24 saacadood inuu runtii aad hoos ugu dhacay," ayuu yiri Dr Wagstaff.
Ivermectin waa daawo kahortaga dulinka oo ay ansixisay FDA oo sidoo kale la muujiyay inay waxtar leedahay Tijaabooyin oo ka dhan ah fayrasyo fara badan oo ay ka mid yihiin HIV, Dengue, Influenza iyo Zika virus.
Dr Wagstaff ayaa ka digay in baaritaanada lagu sameeyay daraasada ay ahaayeen Tijaabooyin iyo in tijaabooyinka loo baahan yahay in lagu qaado dadka.
“Ivermectin aad ayaa loo adeegsadaa loona arkaa inay tahay dawo badbaado leh. Waxaan u baahannahay inaan hadda ogaano in qiyaasta aad ugu adeegsan karto aadanaha ay wax ku ool noqonayso iyo in kale - taasi waa tallaabada xigta, ”ayuu yiri Dr Wagstaff.
- Waqtiyada aynu ku jirno masiibo caalami ah mana jirto daaweyn la oggol yahay, haddii aan lahaan lahayn dhisme laga heli karay adduunka oo dhan markaas ayaa laga yaabaa inuu dadka si dhakhso leh u caawiyo. Xaqiiq ahaan waxay ahaan doontaa xoogaa kahor intaan tallaalka si ballaaran loo helin.
In kasta oo habka uu Ivermectin ugu shaqeeyo fayraska aan la ogeyn, haddana waxay u badan tahay, iyadoo lagu saleynayo ficilkeeda fayrasyada kale, inay ka shaqeyneyso joojinta fayraska 'hoos u dhigaya' unugyada martida loo yahay 'nadiifinta, ayuu yiri Dr Wagstaff.
Isbitaalka Royal Melbourne Hospital Dr Leon Caly, oo ah Saynisyahan Saynis Caafimad oo Shaybaar ah oo laga helo sheybaarka tixraaca cudurada faafa ee Fiktooriya (VIDRL) ee machadka Doherty halkaasoo tijaabooyin lagu sameeyay coronavirus live ah, waa qoraaga ugu horeeya.
"Aniga oo ah khabiir ku takhasusay cilmiga virologist-ka oo ka mid ahaa kooxdii ugu horeysay ee go'doomiya lana wadaaga SARS-COV2 meel ka baxsan Shiinaha bishii Janaayo 2020, waxaan ku faraxsanahay rajada ah in Ivermectin loo isticmaalo daroogada suuragalka ah ee ka dhanka ah COVID-19," ayuu yiri Dr Caly .
Dr Wagstaff waxay sameysay horudhac horudhac ah oo ku saabsan Ivermectin sanadii 2012 markii ay aqoonsatay daroogada iyo waxqabadkeeda kahortaga fayraska Monash Biomedicine Discovery Institute's Professor David Jans, sidoo kale qoraa warqadan ku qoran. Borofisar Jans iyo kooxdiisuba waxay in ka badan 10 sano cilmi baaris ku sameynayeen cudurka Ivermectin oo ay la socdeen fayrasyo kala duwan.
Dr Wagstaff iyo Professor Jans waxay bilaabeen baaritaanka inay ka shaqeynayeen fayraska SARS-CoV-2 isla markii cudurka caabuqa la ogaa inuu bilaabmay.
Isticmaalka Ivermectin si loola dagaallamo COVID-19 waxay ku xirnaan doontaa natiijooyinka baaritaanka hore ee daaweynta iyo ugu dambeyn tijaabooyinka bukaan socodka, iyadoo maalgelin degdeg ah looga baahan yahay inay sii waddo horumarka shaqada, ayuu yiri Dr Wagstaff.
Akhriso warqadda buuxda ee Cilmi-baarista Antiviral ee cinwaankeedu yahay: Daawada "Ivermectin" ee ay ansixisay FDA ayaa horjoogsata soosaarida SARS-CoV-2 ee ku jirta fitiro
Waqtigaan la joogo, ku dhowaad 40 daroogo kale ayaa sidoo kale loo baaraa faa'iidooyinka lagu daaweeyo COVID-19.
MAXAA LAGU QAADAYAA MAQAALKAN:
- Although the mechanism by which Ivermectin works on the virus is not known, it is likely, based on its action in other viruses, that it works to stop the virus ‘dampening down' the host cells' ability to clear it, Dr Wagstaff said.
- "Aniga oo ah khabiir ku takhasusay cilmiga virologist-ka oo ka mid ahaa kooxdii ugu horeysay ee go'doomiya lana wadaaga SARS-COV2 meel ka baxsan Shiinaha bishii Janaayo 2020, waxaan ku faraxsanahay rajada ah in Ivermectin loo isticmaalo daroogada suuragalka ah ee ka dhanka ah COVID-19," ayuu yiri Dr Caly .
- A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.
